Literature DB >> 10840127

Relation between hippocampal gamma waves and behavioral disturbances induced by phencyclidine and methamphetamine.

J Ma1, L S Leung.   

Abstract

The relationship between hippocampal electrical activity and behavioral hyperactivity induced by either phencyclidine (PCP) or methamphetamine (MAP) was examined in freely behaving rats. The EEGs at the hippocampal CA1 region were simultaneously recorded with the animal's behavior for 2 h after administration of either PCP or MAP. PCP (10 mg/kg, intraperitoneal (i.p.)) significantly increased locomotor activity including rearing, walking, head-weaving and circling. Spectral analysis of the EEG showed that hippocampal gamma waves (30-70 Hz), but not other frequency bands, were significantly increased from 5 to 120 min after systemic injection of PCP. Inactivation of the medial septum with muscimol, a gamma-aminobutyric acid receptor A agonist, 15 min prior to injection of PCP, suppressed both hippocampal gamma waves and locomotor activity. MAP (1.5 mg/kg, i.p.) also increased locomotor activity for longer than 2 h. During the behavioral hyperactivity induced by MAP, hippocampal EEG showed θ and gamma rhythms that were not significantly different from those during walking before MAP. However, MAP-induced behavioral activity was suppressed by pre-injection of muscimol in the medial septum, which also decreased hippocampal gamma activity. It is suggested that the medial septum plays a role in mediating behavioral disturbances induced by both PCP and MAP through control of the hippocampal electrical activity, and that hippocampal gamma waves may play a permissible role in the expression of behaviors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10840127     DOI: 10.1016/s0166-4328(00)00138-8

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  35 in total

1.  Effects of phencyclidine (PCP) and MK 801 on the EEGq in the prefrontal cortex of conscious rats; antagonism by clozapine, and antagonists of AMPA-, alpha(1)- and 5-HT(2A)-receptors.

Authors:  Claude Sebban; Brigitte Tesolin-Decros; Jorge Ciprian-Ollivier; Laurent Perret; Michael Spedding
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

2.  NMDAR antagonist action in thalamus imposes δ oscillations on the hippocampus.

Authors:  Yuchun Zhang; Takashi Yoshida; Donald B Katz; John E Lisman
Journal:  J Neurophysiol       Date:  2012-03-14       Impact factor: 2.714

Review 3.  Gamma synchrony: towards a translational biomarker for the treatment-resistant symptoms of schizophrenia.

Authors:  Michael J Gandal; J Christopher Edgar; Kerstin Klook; Steven J Siegel
Journal:  Neuropharmacology       Date:  2011-02-22       Impact factor: 5.250

Review 4.  Impact of ketamine on neuronal network dynamics: translational modeling of schizophrenia-relevant deficits.

Authors:  Bernat Kocsis; Ritchie E Brown; Robert W McCarley; Mihaly Hajos
Journal:  CNS Neurosci Ther       Date:  2013-04-24       Impact factor: 5.243

5.  Dopamine and gamma band synchrony in schizophrenia--insights from computational and empirical studies.

Authors:  Kübra Kömek; G Bard Ermentrout; Christopher P Walker; Raymond Y Cho
Journal:  Eur J Neurosci       Date:  2012-07       Impact factor: 3.386

6.  Effects of GABA-B receptor positive modulator on ketamine-induced psychosis-relevant behaviors and hippocampal electrical activity in freely moving rats.

Authors:  Jingyi Ma; L Stan Leung
Journal:  Psychopharmacology (Berl)       Date:  2017-07-29       Impact factor: 4.530

7.  The supramammillo-septal-hippocampal pathway mediates sensorimotor gating impairment and hyperlocomotion induced by MK-801 and ketamine in rats.

Authors:  Jingyi Ma; L Stan Leung
Journal:  Psychopharmacology (Berl)       Date:  2007-01-12       Impact factor: 4.530

8.  GABA(B) receptor blockade in the hippocampus affects sensory and sensorimotor gating in Long-Evans rats.

Authors:  Jingyi Ma; L Stan Leung
Journal:  Psychopharmacology (Berl)       Date:  2011-04-12       Impact factor: 4.530

9.  Phencyclidine Discoordinates Hippocampal Network Activity But Not Place Fields.

Authors:  Hsin-Yi Kao; Dino Dvořák; EunHye Park; Jana Kenney; Eduard Kelemen; André A Fenton
Journal:  J Neurosci       Date:  2017-11-08       Impact factor: 6.167

10.  Serotonergic lesions of the dorsal hippocampus differentially modulate locomotor hyperactivity induced by drugs of abuse in rats: implications for schizophrenia.

Authors:  Wendy Adams; Scott Ayton; Maarten van den Buuse
Journal:  Psychopharmacology (Berl)       Date:  2009-07-23       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.